Rennova Health Stock Current Valuation
| RNVADelisted Stock | USD 0.0001 0.00 0.00% |
Valuation analysis of Rennova Health helps investors to measure Rennova Health's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Rennova Health's price fluctuation is very steady at this time. Calculation of the real value of Rennova Health is based on 3 months time horizon. Increasing Rennova Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Rennova Health is useful when determining the fair value of the Rennova pink sheet, which is usually determined by what a typical buyer is willing to pay for full or partial control of Rennova Health. Since Rennova Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Rennova Pink Sheet. However, Rennova Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.0E-4 | Real 6.4E-5 | Hype 1.0E-4 | Naive 8.2E-5 |
The real value of Rennova Pink Sheet, also known as its intrinsic value, is the underlying worth of Rennova Health Company, which is reflected in its stock price. It is based on Rennova Health's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Rennova Health's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Rennova Health's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Rennova Health helps investors to forecast how Rennova pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Rennova Health more accurately as focusing exclusively on Rennova Health's fundamentals will not take into account other important factors: Rennova Health Company Current Valuation Analysis
Rennova Health's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Rennova Health Current Valuation | 18.13 M |
Most of Rennova Health's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Rennova Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Rennova Health has a Current Valuation of 18.13 M. This is 99.87% lower than that of the Health Care Providers & Services sector and 99.77% lower than that of the Health Care industry. The current valuation for all United States stocks is 99.89% higher than that of the company.
Rennova Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Rennova Health's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Rennova Health could also be used in its relative valuation, which is a method of valuing Rennova Health by comparing valuation metrics of similar companies.Rennova Health is currently under evaluation in current valuation category among related companies.
Rennova Fundamentals
| Return On Asset | -0.0862 | ||||
| Profit Margin | (0.53) % | ||||
| Operating Margin | (0.30) % | ||||
| Current Valuation | 18.13 M | ||||
| Shares Outstanding | 29.08 B | ||||
| Shares Owned By Institutions | 9.00 % | ||||
| Price To Earning | (0.03) X | ||||
| Price To Sales | 0 X | ||||
| Revenue | 3.22 M | ||||
| Gross Profit | (2.07 M) | ||||
| EBITDA | (1.08 M) | ||||
| Net Income | (5.09 M) | ||||
| Cash And Equivalents | 126.88 K | ||||
| Total Debt | 15.17 M | ||||
| Debt To Equity | 0.81 % | ||||
| Current Ratio | 0.10 X | ||||
| Book Value Per Share | (0) X | ||||
| Cash Flow From Operations | (8.91 M) | ||||
| Short Ratio | 0.84 X | ||||
| Earnings Per Share | (333.88) X | ||||
| Target Price | 555.0 | ||||
| Number Of Employees | 57 | ||||
| Beta | 53.11 | ||||
| Market Capitalization | 2.91 M | ||||
| Total Asset | 19.63 M | ||||
| Retained Earnings | (133.25 M) | ||||
| Working Capital | 6.86 M | ||||
| Current Asset | 7.7 M | ||||
| Current Liabilities | 841 K | ||||
| Z Score | -8.4 | ||||
| Net Asset | 19.63 M |
About Rennova Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Rennova Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Rennova Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Rennova Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Consideration for investing in Rennova Pink Sheet
If you are still planning to invest in Rennova Health check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Rennova Health's history and understand the potential risks before investing.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |